CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and
human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical
cells. Studying biomarkers in abnormal cervical cells may improve the ability to find
cervical lesions and plan effective treatment.
Intervention
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis
Condition
Atypical Endometrial Hyperplasia, Human Papillomavirus Infection, Stage 0 Cervical Cancer AJCC v7
Investigators
Shu-Yuan liao